Suppr超能文献

在山地救援中对有中度或重度疼痛的伤员使用镇痛药。

The use of analgesia in mountain rescue casualties with moderate or severe pain.

机构信息

Birbeck Medical Group, Penrith Health Centre, Bridge Lane, Penrith, Cumbria CA11 8HW, UK.

出版信息

Emerg Med J. 2013 Jun;30(6):501-5. doi: 10.1136/emermed-2012-202291. Epub 2013 Feb 12.

Abstract

OBJECTIVES

To assess the effectiveness of analgesia used in mountain rescue (MR) in casualties with moderate or severe pain. To determine if a verbal numeric pain score is practical in this environment. To describe the analgesic strategies used by MR.

DESIGN

Prospective, descriptive study.

SETTING

Fifty-one MR teams in England and Wales. The study period was 1 September 2008 to 31 August 2010.

PARTICIPANTS

92 MR casualties with a pain scoreof 4/10 or greater.

MAIN OUTCOME

38% of casualties achieved a pain reduction of 50% or greater in their initial score at 15 min and 60.2% had achieved this at handover.

RESULTS

The initial pain score was 8 (median), reducing to 5 at 15 min and 3 at handover. The mean pain reduction was 2.5 ± 2.4 at 15 min and 3.9 ± 2.5 at handover. 80 casualties (87%) were treated with an opioid and seven had two different opioids administered. Seven main strategies were identified in which the principal agent was entonox, intramuscular opioid, oral analgesia, fentanyl lozenge, intranasal or intravenous opioid. The choice of strategy varied with the skills of the casualty carer.

CONCLUSIONS

Pain should be assessed using a pain score. When possible, intravenous opioid is the gold standard to achieve early and continuing pain control in patients with moderate or severe pain. Entonox and oral analgesics, as sole agents, have limited use in moderate or severe pain. Intranasal opioid and fentanyl lozenge are effective, and appropriate in MR. Research priorities include bioavailability in different environmental conditions and patient's satisfaction with their pain management.

摘要

目的

评估在山地救援(MR)中使用的镇痛方法对中度或重度疼痛患者的疗效。确定在这种环境下使用口头数字疼痛评分是否可行。描述 MR 中使用的镇痛策略。

设计

前瞻性描述性研究。

地点

英格兰和威尔士的 51 个 MR 小组。研究期间为 2008 年 9 月 1 日至 2010 年 8 月 31 日。

参与者

92 名 MR 伤员,疼痛评分为 4/10 或更高。

主要结果

在 15 分钟和交接时,分别有 38%和 60.2%的伤员初始评分降低 50%或更多。

结果

初始疼痛评分为 8(中位数),15 分钟时降至 5,交接时降至 3。平均疼痛缓解在 15 分钟时为 2.5±2.4,在交接时为 3.9±2.5。80 名伤员(87%)接受了阿片类药物治疗,7 名伤员接受了两种不同的阿片类药物治疗。确定了七种主要策略,其中主要药物为恩诺昔、肌肉内阿片类药物、口服镇痛剂、芬太尼含片、鼻内或静脉内阿片类药物。策略的选择因伤员护理人员的技能而异。

结论

应使用疼痛评分评估疼痛。在可能的情况下,静脉内阿片类药物是控制中度或重度疼痛患者早期和持续疼痛的金标准。恩诺昔和口服镇痛药作为单一药物,在中度或重度疼痛中使用有限。鼻内阿片类药物和芬太尼含片有效,适用于 MR。研究重点包括在不同环境条件下的生物利用度和患者对疼痛管理的满意度。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验